0
Signin
countryflagCA

888-969-2592

RY 156.04 -0.032% TD 79.81 -0.4615% SHOP 99.81 0.9303% CNR 158.79 0.6401% ENB 53.84 0.4478% CP 111.87 0.8019% BMO 112.71 0.7419% TRI 225.62 0.396% CNQ 50.46 2.4777% BN 67.8 1.194% ATD 76.93 -1.0674% CSU 4321.5298 0.3257% BNS 67.27 1.3102% CM 78.76 1.5603% SU 54.66 -1.1037% TRP 62.42 1.2162% NGT 70.54 0.2558% WCN 251.32 0.3153% MFC 36.65 -0.0818% BCE 47.21 0.3187%

Diagnos Inc

Healthcare CA ADK

0.4CAD
-(-%)

Last update at 2024-08-30T20:00:00Z

Day Range

0.390.41
LowHigh

52 Week Range

0.250.59
LowHigh

Fundamentals

  • Previous Close 0.40
  • Market Cap26.38M
  • Volume63300
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.30653M
  • Revenue TTM0.27M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM -0.30677M
  • Diluted EPS TTM-0.04

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -2.48082M -2.60822M -2.05130M -3.38287M -3.90372M
Minority interest - - - - -
Net income -2.48082M -2.60822M -2.05130M -3.38287M -3.83906M
Selling general administrative 1.93M 2.24M 1.94M 2.32M 2.17M
Selling and marketing expenses - - - - -
Gross profit -0.30677M -0.41830M -0.34753M -0.47346M -0.75937M
Reconciled depreciation 0.10M 0.11M 0.09M 0.10M 0.19M
Ebit - -2.65996M -2.28342M -2.79635M -2.92997M
Ebitda -2.10073M -2.44864M -1.93170M -2.93404M -2.68697M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -2.22167M -2.65996M -2.28342M -2.79635M -2.92997M
Other operating expenses - - - - -
Interest expense 0.28M 0.05M 0.03M 0.35M 1.03M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M -0.06467M
Interest income 0.00777M 0.00538M - 0.00323M -
Net interest income -0.27114M -0.04840M -0.03216M -0.34388M -1.02543M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -0.06467M
Total revenue 0.49M 0.44M 0.27M 0.33M 0.33M
Total operating expenses 2.71M 3.10M 2.55M 3.13M 3.26M
Cost of revenue 0.79M 0.86M 0.61M 0.80M 1.09M
Total other income expense net 0.01M 0.10M 0.26M -0.24264M 0.05M
Discontinued operations - - - - -
Net income from continuing ops -2.48082M -2.60822M -2.05130M -3.38287M -3.83906M
Net income applicable to common shares - -2.60822M -2.05130M -3.38287M -3.83906M
Preferred stock and other adjustments - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 0.82M 1.54M 1.95M 2.43M 1.21M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.02M 0.02M 0.03M 0.02M 0.02M
Total liab 2.77M 1.66M 0.82M 0.61M 6.29M
Total stockholder equity -1.94821M -0.11351M 1.13M 1.82M -5.08260M
Deferred long term liab - - - - -
Other current liab 0.00671M 0.00667M 0.00417M 0.00417M 0.00417M
Common stock 35.91M 35.68M 34.76M 33.67M 23.70M
Capital stock 35.91M 35.68M 34.76M 33.67M 23.70M
Retained earnings -47.52636M -44.99246M -42.38424M -40.33294M -36.95007M
Other liab - - - - -
Good will - - - - -
Other assets - - 0.03M 0.03M -
Cash 0.30M 0.42M 0.36M 0.57M 0.14M
Cash and equivalents - - - - -
Total current liabilities 0.72M 0.66M 0.55M 0.58M 2.48M
Current deferred revenue - - - - -
Net debt 1.77M 0.54M - - 5.31M
Short term debt - - - - 1.67M
Short long term debt 0.17M 0.12M 0.12M 0.27M 1.67M
Short long term debt total - - - - -
Other stockholder equity 9.66M 9.20M 8.76M 8.49M 8.17M
Property plant equipment 0.25M 0.25M 0.33M 0.06M 0.10M
Total current assets 0.57M 1.29M 1.59M 2.34M 1.09M
Long term investments - 0.00000M 0.03M 0.03M 0.01000M
Net tangible assets - -0.11351M 1.13M 1.82M -5.08260M
Short term investments 0.00000M 0.50M 1.00M 1.30M 0.56M
Net receivables 0.24M 0.33M 0.18M 0.32M 0.37M
Long term debt 1.90M 0.83M 0.04M - 3.78M
Inventory - - - - -
Accounts payable 0.29M 0.28M 0.19M 0.07M 0.14M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 0.11M
Deferred long term asset charges - - - - -
Non current assets total 0.25M 0.25M 0.36M 0.10M 0.11M
Capital lease obligations 0.24M 0.23M 0.31M 0.07M 0.07M
Long term debt total - - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments 0.50M 0.53M 0.30M -0.76449M -0.02616M
Change to liabilities -0.00259M 0.12M 0.07M 0.05M 0.12M
Total cashflows from investing activities 0.47M 0.50M 0.26M -0.75998M -0.09647M
Net borrowings 1.40M 0.89M -0.20683M 0.47M 0.78M
Total cash from financing activities 1.28M 1.60M 0.88M 3.83M 2.40M
Change to operating activities 0.00677M 0.00446M 0.10M -0.11385M 0.01M
Net income -2.48082M -2.60822M -2.05130M -3.38287M -3.83906M
Change in cash -0.12427M 0.06M -0.21105M 0.43M -0.01205M
Begin period cash flow 0.42M 0.36M 0.57M 0.14M 0.15M
End period cash flow 0.30M 0.42M 0.36M 0.57M 0.14M
Total cash from operating activities -1.88381M -2.03794M -1.35680M -2.64071M -2.31972M
Issuance of capital stock 0.00000M 0.72M 1.11M 3.40M -
Depreciation 0.10M 0.11M 0.09M 0.10M 0.19M
Other cashflows from investing activities -0.00105M 0.00454M 0.00511M 0.02M -0.03164M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory - - - - -
Change to account receivables 0.08M -0.14224M 0.14M 0.05M 0.21M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.11835M -0.02280M -0.01760M -0.03430M -0.32416M
Change to netincome 0.39M 0.48M 0.30M 0.66M 0.98M
Capital expenditures 0.02M 0.03M 0.04M 0.02M 0.04M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.09M -0.01498M 0.31M -0.02026M 0.35M
Stock based compensation 0.17M 0.43M 0.25M 0.13M 0.22M
Other non cash items 0.12M 0.03M 0.03M 0.38M 0.49M
Free cash flow -1.90804M -2.06895M -1.39898M -2.65583M -2.36200M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ADK
Diagnos Inc		 - -% 0.40 - 9.75 99.08 54.61 112.33 -13.5942
RHT
Reliq Health Technologies Inc		 - -% 0.21 - - 3.19 5.12 4.07 -10.7759
NURS
Hydreight Technologies Inc		 - -% 0.25 - - 1.33 - 1.08 -1.7505
NEWU
Newtopia Inc		 - -% 0.03 - - 1.13 116.97 2.00 -6.0385
OKAI
EvokAI Creative Labs Inc.		 0.005 14.29% 0.04 - - 774.43 - -21.0977

Reports Covered

Stock Research & News

View All

Profile

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Diagnos Inc

7005 Taschereau Boulevard, Brossard, QC, Canada, J4Z 1A7

Key Executives

Name Title Year Born
Mr. Andre Larente CEO, Pres & Exec. Director NA
Mr. Marc-André Massue VP of Fin., CFO & Sec. NA
Mr. Guillermo Moreno Robles VP of Sales NA
Mr. Martin Beland Director of Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.